Chest wall and axillary lymph node FDG uptake associated with cancer vaccine therapy for lung cancer

Clinical Nuclear Medicine

Volumn 35, Issue 9, 2010, Pages 729-730

  Kaneko, Koichiro ^a   Yoshida, Tsuyoshi ^a   Hiyama, Junichiro ^b   Ono, Ken ^a   Omagari, Junichi ^a  

^a Koga Hospital 21   (Japan)

^b SHIN KOGA HOSPITAL   (Japan)

Author keywords

FDG PET and PET CT; FDG uptake in the chest wall and axillary lymph node; personalized peptide vaccine therapy

Indexed keywords

CANCER VACCINE; CARBOPLATIN; CISPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; PACLITAXEL; PEPTIDE VACCINE;

AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER IMMUNIZATION; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG ACCUMULATION; DRUG UPTAKE; FEMALE; HUMAN; INJECTION SITE REACTION; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; RECURRENT CANCER; THORAX WALL;

AGED; AXILLA; CANCER VACCINES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MALE; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; SMALL CELL LUNG CARCINOMA; THORACIC WALL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955950329     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181ea33bb     Document Type: Article

References (10)

1. Uesaka D, Demura Y, Ishizaki T, et al. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer. J Nucl Med. 2008; 49:1606-1612.
2. Shinya T, Rai K, Okumura Y, et al. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer. Clin Nucl Med. 2009;34:216-221.
3. Yajima N, Yamanaka R, Mine T, et al. Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma. Clin Cancer Res. 2005;11:5900-5911.
4. Itoh K, Yamada A. Personalized peptide vaccines: a new therapeutic modality for cancer. Cancer Sci. 2006;97:970-976.
5. Hattori T, Mine T, Komatsu N, et al. Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients. Cancer Immunol Immunother. 2009;58:1843-1852.
6. Jones RL, Cunningham D, Cook G, et al. Tumour vaccine associated lymphadenopathy and false positive positron emission tomography scan changes. Br J Radiol. 2004;77:74-75.
7. Marchal G, Oyen R, Verschakelen J, et al. Sonographic appearance of normal lymph nodes. J Ultrasound Med. 1985;4:417-419.
8. Vassallo P, Wernecke K, Roos N, et al. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology. 1992;183:215-220.
9. Ariji Y, Kimura Y, Hayashi N, et al. Power Doppler sonography of cervical lymph nodes in patients with head and neck cancer. Am J Neuroradiol. 1998;19:303-307.
10. Torabi M, Aquino SL, Harisinghani MG. Current concepts in lymph node imaging. J Nucl Med. 2004;45:1509-1518.